Focus on Drug-Makers’ Marketing

The news last week was filled with various reports concerning the manner in which pharmaceutical manufacturers market their products, such as OxyContin, anemia medicines, and atypical psychotics, including ways in which doctors are encouraged to prescribe their products, even to children. The U.S. Senate passed, by a vote of 93-1, a bill that gives the Food and Drug Administration additional authority to regulate drug advertising, among other powers such as the ability to order changes in drug labels.

The bill was passed in large part as a reaction to the experience with Vioxx, where it took 14 months to change … Read the rest